Page last updated: 2024-10-20

pyrazinamide and Bagassosis

pyrazinamide has been researched along with Bagassosis in 2 studies

pyrazinecarboxamide : A monocarboxylic acid amide resulting from the formal condensation of the carboxy group of pyrazinoic acid (pyrazine-2-carboxylic acid) with ammonia. A prodrug for pyrazinoic acid, pyrazinecarboxamide is used as part of multidrug regimens for the treatment of tuberculosis.

Bagassosis: A diffuse parenchymal lung disease caused by inhaled dust from processing SUGARCANE (bagasse), usually in the manufacturing of wallboard.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19902 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
CORPE, RF1
Lin, TP1
Suo, J1
Lee, CN1
Lee, JJ1
Yang, SP1

Trials

1 trial available for pyrazinamide and Bagassosis

ArticleYear
Short-course chemotherapy of pulmonary tuberculosis in pneumoconiotic patients.
    The American review of respiratory disease, 1987, Volume: 136, Issue:4

    Topics: Adult; Aged; Antitubercular Agents; Clinical Trials as Topic; Drug Therapy, Combination; Humans; Iso

1987

Other Studies

1 other study available for pyrazinamide and Bagassosis

ArticleYear
CLINICAL ASPECTS, MEDICAL AND SURGICAL, IN THE MANAGEMENT OF BATTEY-TYPE PULMONARY DISEASE.
    Diseases of the chest, 1964, Volume: 45

    Topics: Bronchiectasis; Calcification, Physiologic; Drug Resistance; Drug Resistance, Microbial; Epidemiolog

1964